Direct enantiomeric resolution of disopyramide and its metabolite using chiral high-performance liquid chromatography. Application to stereoselective metabolism and pharmacokinetics of racemic disopyramide in man.
A method for the simultaneous determination of disopyramide and mono-N-desisopropyldisopyramide enantiomers extracted from human plasma and urine is presented. Separation and quantitation were carried out using two columns coupled in series, and UV detection at 254 nm. First, the racemates of the two compounds were separated using a reversed-phase column, and then the enantiomers were separated using a stereoselective column packed with human alpha 1-acid glycoprotein. The mobile phase was 8 mM phosphate buffer, pH 6.20-2-propanol (92:8, v/v). The coefficients of variation (%) for the plasma daily determination were 6.7% for R(-)- and S(+)-disopyramide at drug levels of 1.5 micrograms/ml, and 8.5% and 7.7% for R(-)- and S(+)-mono-N-desisopropyldisopyramide, respectively, at drug levels of 0.375 micrograms/ml. The method has allowed the study of stereoselective metabolism and pharmacokinetics of disopyramide after oral administration as a racemate.
Le Corre
P
P
Laboratoire de Pharmacie Galénique et Biopharmacie, Université de Rennes I, France.
Gibassier
D
D
Sado
P
P
Le Verge
R
R
D000284:Administration, Oral; D002851:Chromatography, High Pressure Liquid; D004206:Disopyramide / Q000031:analogs & derivatives / Q000302:isolation & purification* / Q000378:metabolism / Q000493:pharmacokinetics; D006801:Humans; D007202:Indicators and Reagents; D013237:Stereoisomerism
D007202:Indicators and Reagents; C030438:4-(isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide; D004206:Disopyramide